Memphis Pharmaceutical & Chemical Industries (MPCI) Revenue
Revenue
EGP 1.8B
Trailing 12 months (TTM)
As of 23 Jul 2026, 19:29 (Cairo time)
Revenue (also called sales or turnover) is the total income a company generates from its core business before any costs or expenses are deducted. For EGX-listed companies it is reported in the annual income statement in Egyptian pounds.
Revenue history
| Fiscal year | Revenue | YoY growth |
|---|---|---|
| 2025 | 1.51B | 72.93% |
| 2024 | 871.91M | 31.34% |
| 2023 | 663.83M | 20.42% |
| 2022 | 551.26M | 6.4% |
| 2021 | 518.11M | 5.72% |
| 2020 | 490.1M | 33.6% |
| 2019 | 366.84M | 6.84% |
| 2018 | 343.36M | 37.23% |
| 2017 | 250.21M | -30.07% |
| 2016 | 357.8M | -9.68% |
| 2015 | 396.15M | -6.28% |
| 2014 | 422.68M | 6.14% |
| 2013 | 398.22M | 42.74% |
| 2012 | 278.99M | -20.51% |
| 2011 | 350.99M | — |
| 2009 | 445.51M | — |
| 2006 | 174.11M | 6.74% |
| 2005 | 163.12M | — |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.